{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T08:48:11Z","timestamp":1774946891894,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T00:00:00Z","timestamp":1717632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T00:00:00Z","timestamp":1717632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Digit Imaging. Inform. med."],"DOI":"10.1007\/s10278-024-01153-3","type":"journal-article","created":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T18:03:16Z","timestamp":1717696996000},"page":"2865-2873","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Identification of Prolactinoma in Pituitary Neuroendocrine Tumors Using Radiomics Analysis Based on Multiparameter MRI"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1390-1951","authenticated-orcid":false,"given":"Hongxia","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuwei","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9335-9140","authenticated-orcid":false,"given":"Qingshi","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,6]]},"reference":[{"issue":"suppl_4","key":"1153_CR1","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noy131","volume":"20","author":"QT Ostrom","year":"2018","unstructured":"Ostrom QT, Gittleman H, Truitt G, Boscia A, Kruchko C, Barnholtz-Sloan JS: CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011\u20132015. Neuro Oncol 20(suppl_4):iv1\u2013iv86, 2018","journal-title":"Neuro Oncol"},{"key":"1153_CR2","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.beem.2009.05.003","volume":"23","author":"A Colao","year":"2009","unstructured":"Colao A: Pituitary tumours: the prolactinoma. Best Pract Res Clin Endocrinol Metabol 23:575\u201396, 2009","journal-title":"Best Pract Res Clin Endocrinol Metabol"},{"issue":"1","key":"1153_CR3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s12022-022-09703-7","volume":"33","author":"SL Asa","year":"2022","unstructured":"Asa SL, Mete O, Perry A, Osamura RY: Overview of the 2022 WHO Classification of Pituitary Tumors. Endocr Pathol 33(1):6\u201326, 2022","journal-title":"Endocr Pathol"},{"issue":"5","key":"1153_CR4","doi-asserted-by":"publisher","first-page":"473","DOI":"10.4158\/EP-2018-0034","volume":"24","author":"CT Lim","year":"2018","unstructured":"Lim CT, Korbonits M: Update on the clinicopathology of pituitary adenomas. Endocr Pract 24(5):473\u2013488, 2018","journal-title":"Endocr Pract"},{"issue":"1","key":"1153_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11102-019-00997-1","volume":"23","author":"MBS Lopes","year":"2020","unstructured":"Lopes MBS: Pathology of prolactinomas: any predictive value? Pituitary 23(1):3\u20138, 2020","journal-title":"Pituitary"},{"key":"1153_CR6","doi-asserted-by":"publisher","first-page":"1123267","DOI":"10.3389\/fendo.2023.1123267","volume":"14","author":"A Bianchi","year":"2023","unstructured":"Bianchi A, et al.: Multidisciplinary management of difficult\/aggressive growth-hormone pituitary neuro-endocrine tumors. Front Endocrinol (Lausanne) 14:1123267, 2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"1153_CR7","doi-asserted-by":"publisher","first-page":"101521","DOI":"10.1016\/j.beem.2021.101521","volume":"35","author":"OA Hakami","year":"2021","unstructured":"Hakami OA, Ahmed S, Karavitaki N: Epidemiology and mortality of Cushing\u2019s syndrome. Best Pract Res Clin Endocrinol Metab 35(1):101521, 2021","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"3","key":"1153_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/EJE-21-0977","volume":"186","author":"R Cozzi","year":"2022","unstructured":"Cozzi R, et al.: Italian Association of Clinical Endocrinologists (AME) and International Chapter of Clinical Endocrinology (ICCE). Position statement for clinical practice: prolactin-secreting tumors. Eur J Endocrinol 186(3): P1-P33, 2022","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"1153_CR9","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.3390\/medicina58081095","volume":"58","author":"WJ Inder","year":"2022","unstructured":"Inder WJ, Jang C: Treatment of Prolactinoma. Medicina (Kaunas) 58(8):1095, 2022","journal-title":"Medicina (Kaunas)"},{"key":"1153_CR10","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/S0140-6736(79)92976-3","volume":"1","author":"AM Landolt","year":"1979","unstructured":"Landolt AM, Wuthrich R, Fellmann H: Regression of pituitary prolactinoma after treatment with bromocriptine. Lancet 1: 1082\u20131083, 1979","journal-title":"Lancet"},{"issue":"8133","key":"1153_CR11","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S0140-6736(79)90120-X","volume":"2","author":"JA Wass","year":"1979","unstructured":"Wass JA, et al.: Reduction of pituitary-tumour size in patients with prolactinomas and acromegaly treated with bromocriptine with or without radiotherapy. Lancet 14;2(8133): 66\u2009\u2013\u20099, 1979","journal-title":"Lancet"},{"issue":"2","key":"1153_CR12","doi-asserted-by":"publisher","first-page":"236","DOI":"10.20945\/2359-3997000000032","volume":"62","author":"L Vilar","year":"2018","unstructured":"Vilar L, et al.: Controversial issues in the management of hyperprolactinemia and prolactinomas - An overview by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism. Arch Endocrinol Metab 62(2):236\u2013263, 2018","journal-title":"Arch Endocrinol Metab"},{"key":"1153_CR13","unstructured":"PDQ Adult Treatment Editorial Board: Pituitary Tumors Treatment (PDQ): Health Professional Version (2022) Available via https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK66024\/. Accessed 4 Nov 2022"},{"key":"1153_CR14","doi-asserted-by":"publisher","first-page":"103966","DOI":"10.1016\/j.compbiomed.2020.103966","volume":"124","author":"LF Machado","year":"2020","unstructured":"Machado LF, Elias PCL, Moreira AC, Dos Santos AC, Murta Junior LO: MRI radiomics for the prediction of recurrence in patients with clinically non-functioning pituitary macroadenomas. Comput Biol Med 124:103966, 2020","journal-title":"Comput Biol Med"},{"issue":"3","key":"1153_CR15","doi-asserted-by":"publisher","first-page":"495","DOI":"10.3390\/brainsci13030495","volume":"15","author":"MM Rech","year":"2023","unstructured":"Rech MM, et al.: Machine Learning Models to Forecast Outcomes of Pituitary Surgery: A Systematic Review in Quality of Reporting and Current Evidence. Brain Sci 15;13(3):495, 2023","journal-title":"Brain Sci"},{"key":"1153_CR16","doi-asserted-by":"publisher","first-page":"754503","DOI":"10.3389\/fgene.2021.754503","volume":"20","author":"S Cheng","year":"2021","unstructured":"Cheng S, et al.: A Novel Three-LncRNA Signature Predicting Tumor Recurrence in Nonfunctioning Pituitary Adenomas. Front Genet 20;12:754503, 2021","journal-title":"Front Genet"},{"issue":"4","key":"1153_CR17","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s11102-021-01128-5","volume":"24","author":"S Shahrestani","year":"2021","unstructured":"Shahrestani S, et al.: Neural network modeling for prediction of recurrence, progression, and hormonal non-remission in patients following resection of functional pituitary adenomas. Pituitary 24(4):523\u2013529, 2021","journal-title":"Pituitary"},{"key":"1153_CR18","unstructured":"Li H, et al.: Preoperatively Predicting Ki67 Expression in Pituitary Adenomas Using Deep Segmentation Network and Radiomics Analysis Based on Multiparameter MRI. Acad Radiol S1076-6332(23)00278-7, 2023"},{"issue":"6","key":"1153_CR19","doi-asserted-by":"publisher","first-page":"E5","DOI":"10.3171\/2020.3.FOCUS2060","volume":"48","author":"M Zoli","year":"2020","unstructured":"Zoli M, et al.: Machine learning-based prediction of outcomes of the endoscopic endonasal approach in Cushing disease: is the future coming? Neurosurg Focus 48(6):E5, 2020","journal-title":"Neurosurg Focus"},{"key":"1153_CR20","doi-asserted-by":"publisher","first-page":"640375","DOI":"10.3389\/fonc.2021.640375","volume":"11","author":"CX Liu","year":"2021","unstructured":"Liu CX, Heng LJ, Han Y: Usefulness of the Texture Signatures Based on Multiparametric MRI in Predicting Growth Hormone Pituitary Adenoma Subtypes. Front Oncol 11:640375, 2021","journal-title":"Front Oncol"},{"key":"1153_CR21","doi-asserted-by":"publisher","first-page":"108892","DOI":"10.1016\/j.ejrad.2020.108892","volume":"125","author":"A Peng","year":"2020","unstructured":"Peng A, et al.: A machine learning model to precisely immunohistochemically classify pituitary adenoma subtypes with radiomics based on preoperative magnetic resonance imaging. Eur J Radiol 125:108892, 2020","journal-title":"Eur J Radiol"},{"issue":"12","key":"1153_CR22","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrclinonc.2017.141","volume":"14","author":"P Lambin","year":"2017","unstructured":"Lambin P, et al.: Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol 14(12):749\u2013762, 2017","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"1153_CR23","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.euf.2021.05.005","volume":"8","author":"M Kozikowski","year":"2022","unstructured":"Kozikowski M, et al.: Role of Radiomics in the Prediction of Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis. Eur Urol Focus 8(3):728\u2013738, 2022","journal-title":"Eur Urol Focus"},{"issue":"2","key":"1153_CR24","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s11154-020-09557-6","volume":"21","author":"JF Bonneville","year":"2020","unstructured":"Bonneville JF, Potorac J, Beckers A: Neuroimaging of aggressive pituitary tumors. Rev Endocr Metab Disord 21(2):235\u2013242, 2020","journal-title":"Rev Endocr Metab Disord"},{"issue":"2","key":"1153_CR25","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s11102-018-0928-9","volume":"22","author":"JF Bonneville","year":"2019","unstructured":"Bonneville JF: A plea for the T2W MR sequence for pituitary imaging. Pituitary 22(2):195\u20137, 2019","journal-title":"Pituitary"},{"key":"1153_CR26","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/978-3-319-29043-0_11","volume-title":"Cavernous sinus invasion in MRI of the pituitary gland","author":"JF Bonneville","year":"2016","unstructured":"Bonneville JF, et al. (2016) Cavernous sinus invasion in MRI of the pituitary gland. US: Springer p77\u201383,\u00a0"},{"issue":"3","key":"1153_CR27","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.ecl.2020.06.002","volume":"49","author":"J MacFarlane","year":"2020","unstructured":"MacFarlane J, et al.: Advances in the Imaging of Pituitary Tumors. Endocrinol Metab Clin North Am 49(3):357\u2013373, 2020","journal-title":"Endocrinol Metab Clin North Am"}],"container-title":["Journal of Imaging Informatics in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10278-024-01153-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10278-024-01153-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10278-024-01153-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T19:06:00Z","timestamp":1733166360000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10278-024-01153-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,6]]},"references-count":27,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1153"],"URL":"https:\/\/doi.org\/10.1007\/s10278-024-01153-3","relation":{},"ISSN":["2948-2933"],"issn-type":[{"value":"2948-2933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,6]]},"assertion":[{"value":"22 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the Second Hospital of Shandong University (Ethics approval number: KYLL-2023-422).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}